Intelligence · Clinical Development
Pipeline search results
Programs matching “fostamatinib disodium” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 7 pipeline programs matching "fostamatinib disodium" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Fostamatinib disodium
RIGEL PHARMACEUTICALS INC
Immune Thrombocytopenic Purpura
3 trials -
Fostamatinib disodium
RIGEL PHARMACEUTICALS INC
Warm Antibody Autoimmune Hemolytic Anemia
2 trials -
Fostamatinib Disodium
RIGEL PHARMACEUTICALS INC
T Cell Lymphoma
1 trial -
Fostamatinib Disodium (R935788)
RIGEL PHARMACEUTICALS INC
Systemic Lupus Erythematosus
1 trial -
Fostamatinib Disodium / R935788
RIGEL PHARMACEUTICALS INC
Purpura, Thrombocytopenic, Idiopathic
1 trial -
Fostamatinib Disodium tablet 100 mg
RIGEL PHARMACEUTICALS INC
IGA Nephropathy
1 trial -
Fostamatinib disodium (R935788)
RIGEL PHARMACEUTICALS INC
Rheumatoid Arthritis
2 trials
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.